10:31 AM EST - Avivagen Inc. : Has received approval by the TSX Venture Exchange to extend the expiry date of outstanding warrants exercisable to purchase 1,163,738 common shares at $1.00 per share. Such warrants were issued by Avivagen on December 16, 2014 by way of a private placement and previously had an expiry date of December 16, 2017, which was later extended to June 30, 2018. The new expiry date is October 1, 2018. Avivagen Inc.
shares V.VIV are trading unchanged at $0.88.
